Latest News

Tirzepatide Linked to Lower Cardiorenal Events vs Dulaglutide
Written by: Radcliffe CKM
Tirzepatide Linked to Lower Cardiorenal Events vs Dulaglutide
Sex Influences DAPT De-escalation Outcomes Post-PCI
Written by: Interventional Cardiology
Sex Influences DAPT De-escalation Outcomes Post-PCI
SOUL: Oral Semaglutide Improves CV Risk Factors in T2D
Written by: Radcliffe CKM
SOUL: Oral Semaglutide Improves CV Risk Factors in T2D
Finerenone Approved in EU for HF with LVEF ≥40%
Written by: Heart Failure Academy
Finerenone Approved in EU for HF with LVEF ≥40%
hsCRP Improves CV Risk Prediction in Primary Prevention
Written by: Radcliffe CVRM
hsCRP Improves CV Risk Prediction in Primary Prevention
Smartwatch Screening Boosts AF Detection in High-Risk Patients
Written by: Arrhythmia Academy
Smartwatch Screening Boosts AF Detection in High-Risk Patients
Ez-PAVE: Lower LDL-C Target Reduces CV Events
Written by: Radcliffe CVRM
Ez-PAVE: Lower LDL-C Target Reduces CV Events
LBBAP Not Non-Inferior to BiVP for CRT in LBBB Patients
Written by: Arrhythmia and Electrophysiology Review
LBBAP Not Non-Inferior to BiVP for CRT in LBBB Patients
PFA for Atrial Flutter: ADVANTAGE AF Substudy Results
Written by: Arrhythmia Academy
PFA for Atrial Flutter: ADVANTAGE AF Substudy Results
Smartwatch Data Predicts Heart Failure Exacerbations
Written by: CFR Journal
Smartwatch Data Predicts Heart Failure Exacerbations